Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 162

Sort by

Sort Order Select

Journal Articles

Non-Canonical MYD88/TIRAP-Dependent Anti-Inflammatory Function of Pro-Coagulant Factor VIII

Sandra Mignot, Sandrine Delignat, PhD, Sebastien Lacroix-demaze, PhD, Christine Bole-Feysot, PhD, Sherine Tei, Ananthy Kiddinan, Olivier Hermine, MD PhD, Laurent Frenzel, MD PhD

Blood (2019) 134 (Supplement_1): 3638.

https://doi.org/10.1182/blood-2019-127504

Published: 2019

Journal Articles

Utility of FDG-PET/CT in Lymphoblastic Lymphoma

Thomas A Fox, BSc, MSc, MRCP, Ben Carpenter, PhD, Asim Khwaja, Richard Halsey, MRCP, Victoria Grandage, Marc R. Mansour, MD PhD FRCPath, Adele K. Fielding, MBBS,PhDFRCP,FRCPath, Rachael E Hough, MD

Blood (2019) 134 (Supplement_1): 2890.

https://doi.org/10.1182/blood-2019-127379

Published: 2019

Journal Articles

Polymorphisms in Inflammatory Genes Modulate the Occurrence of Clinical Complications in Patients with Sickle Cell Disease

Blood (2019) 134 (Supplement_1): 4825.

https://doi.org/10.1182/blood-2019-124218

Published: 2019

Journal Articles

A Polymorphism in Toll-like Receptor 2 Gene Is Associated with Occurrence of Bacterial Infections in Sickle Cell Disease Patients

Blood (2018) 132 (Supplement 1): 3652.

https://doi.org/10.1182/blood-2018-99-112296

Published: 2018

Journal Articles

A Clinical Study of Tomaralimab (OPN-305), a Toll-like Receptor 2 (TLR-2) Antibody, in Heavily Pre-Treated Transfusion Dependent Patients with Lower Risk Myelodysplastic Syndromes (MDS) That Have Received and Failed on Prior Hypomethylating Agent (HMA) Therapy

Guillermo Garcia-Manero, MD, Elias J. Jabbour, MD, Marina Y. Konopleva, MD PhD, Naval G. Daver, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, Prithviraj Bose, MD, Parita Patel, Rami S. Komrokji, MD, Aditi Shastri, MD, Gail J. Roboz, MD, Robert Matthew Miller, MD, Sarah Arbe-Barnes, PhD, Mary Reilly, MSc, Peter McGuirk, PhD, Tara Kearney, Brian Keogh, PhD, Hagop M. Kantarjian, MD

Blood (2018) 132 (Supplement 1): 798.

https://doi.org/10.1182/blood-2018-99-119805

Published: 2018

Journal Articles

Inhibition of High Mobility Group Box-1 (HMGB1) Eradicates Human Myelodysplastic Syndrome

Angel Y.F. Kam, PhD, Sadhna O. Piryani, BS, Chad M. McCall, MD PhD, Hee Su Park, Nelson J. Chao, MD, Phuong L. Doan, MD

Blood (2018) 132 (Supplement 1): 4348.

https://doi.org/10.1182/blood-2018-99-119658

Published: 2018

Journal Articles

Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS

Darlene A. Monlish, Sima T. Bhatt, Eric J. Duncavage, Zev J. Greenberg, John L. Keller, Molly P. Romine, Wei Yang, Peter D. Aplan, Matthew J. Walter, Laura G. Schuettpelz

Blood (2018) 131 (9): 1032–1035.

https://doi.org/10.1182/blood-2017-08-801944

Published: 2018

Includes: Supplemental data

Journal Articles

Acquired Somatic Mutations in T Cells in Patients with Aplastic Anemia and Hypoplastic Myelodysplastic Syndromes

Sofie Lundgren, Mikko Keränen, MD PhD, Kari Nousiainen, Samuli Eldfors, Sari Hannula, Tiina Hannunen, Pekka Ellonen, Gunilla Walldin, Michael Clemente, Freja Ebeling, MD PhD, Hanna Rajala, MD PhD, Jaroslaw P. Maciejewski, PhD MD FACP, Harri Lähdesmäki, PhD, Eva Hellstrom-Lindberg, MD PhD, Satu Mustjoki, MDPhD

Blood (2017) 130 (Supplement 1): 1169.

https://doi.org/10.1182/blood.V130.Suppl_1.1169.1169

Published: 2017

Journal Articles

Elucidation of Autoinflammatory Mechanism in Pigt-PNH

Makiko Osato, MS, Yoshiko Murakami, MD PhD, Shogo Murata, MD PhD, Jun-Ichi Nishimura, MD PhD, Yasutaka Ueda, MD PhD, Taroh Kinoshita, PhD, Yuzuru Kanakura, MD PhD

Blood (2017) 130 (Supplement 1): 2201.

https://doi.org/10.1182/blood.V130.Suppl_1.2201.2201

Published: 2017

Journal Articles

Stromal-Cells Downregulate MiR-23a-5p Levels in Myeloid Leukemic Cells to Activate Protective-Autophagy Against Chemotherapeutic Agents

Saravanan Ganesan, MSc, Hamenth kumar Palani, MSc, Vairavan Lakshmanan, B.Tech, Nithya Balasundaram, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Arvind Venkatraman, M.Tech, Uday Prakash Kulkarni, MD DM, Biju George, MDDM, Alok Srivastava, MD, Poonkuzhali Balasubramanian, MSc, PhD, Keshava K Datta, MSc, Harsha Gowda, PhD, Dasaradhi Palakodeti, PhD, Neha Vyas, PhD, Vikram Mathews, MD DM

Blood (2017) 130 (Supplement 1): 3780.

https://doi.org/10.1182/blood.V130.Suppl_1.3780.3780

Published: 2017

Journal Articles

Innate Immune Activation Via TLR9 May Enhance Antibody Formation Against Factors VIII and IX in Protein and Gene Therapy

Roland W Herzog, PhD, Alexandra Sherman, DVM, Brad E. Hoffman, PhD

Blood (2017) 130 (Supplement 1): 3651.

https://doi.org/10.1182/blood.V130.Suppl_1.3651.3651

Published: 2017

Journal Articles

Identification of Somatic Mutations in Expanded T Cell Clones of Patients with Chronic Graft-Versus-Host Disease (GVHD)

Giljun Park, PhD, Daehong Kim, Sofie Lundgren, Rajiv K Khajuria, Ana M Hurtado, Cecilia Muñoz-Calleja, Dra, Laura Cardeñoso, Samuli Eldfors, Pekka Ellonen, Sari Hannula, Oscar Brück, Anna Kreutzman, PhD, Andres Jerez, Maija Itälä-Remes, MD PhD, Mikko A Keränen, MD PhD, Satu Mustjoki, MDPhD

Blood (2017) 130 (Supplement 1): 4487.

https://doi.org/10.1182/blood.V130.Suppl_1.4487.4487

Published: 2017

Journal Articles

Loss of Toll-like Receptor 2 Results in Accelerated Leukemogenesis in the NUP98-HOXD13 Mouse Model of MDS

Darlene A. Monlish, PhD, Sima T. Bhatt, MD, Eric J. Duncavage, MD, Zev J. Greenberg, BS, John L. Keller, BS, Matthew J. Walter, MD, Laura G. Schuettpelz, MD PhD

Blood (2017) 130 (Supplement 1): 48.

https://doi.org/10.1182/blood.V130.Suppl_1.48.48

Published: 2017

Journal Articles

Ruxolitinib Inhibits Toll-like Receptor or GM-CSF, but Not TREM-1 Mediated Neutrophil Activation

Pamela Aranda Lopez, PhD, Astrid Alflen, MD, Nicole Stadler, Cornelia Schmidt, Thomas Kindler, MD, Matthias Theobald, MD PhD, Markus P. Radsak, MD

Blood (2017) 130 (Supplement 1): 4805.

https://doi.org/10.1182/blood.V130.Suppl_1.4805.4805

Published: 2017

Journal Articles

Toll-like Receptor 2 Costimulation Potentiates the Antitumor Efficacy of CAR T Cells

Peng Li, PhD, Xin Du, Yunxin Lai, PhD, Jianyu Weng, Qin Le, Yangqiu Li

Blood (2017) 130 (Supplement 1): 5046.

https://doi.org/10.1182/blood.V130.Suppl_1.5046.5046

Published: 2017

Journal Articles

Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2

Blood (2017) 130 (4): 542–553.

https://doi.org/10.1182/blood-2016-11-754416

Published: 2017

Includes: Multimedia, Supplemental data

Journal Articles

Toll-Like Receptors: Mechanism and Relation to Human Populations

Jane Freedman, MD

Blood (2016) 128 (22): SCI-46.

https://doi.org/10.1182/blood.V128.22.SCI-46.SCI-46

Published: 2016

Journal Articles

Extracellular Tyrosyl-tRNA Synthetase Is a Potent Stimulator of Thrombocytopoiesis

Sachiko Kanaji, MD PhD, Taisuke Kanaji, MD PhD, My-Nuong Vo, PhD, Alessandro Zarpellon, PhD, Ryan Shapiro, Rajesh Belani, MD, Minh-Ha Do, PhD, Xiang-Lei Yang, PhD, Zaverio M. Ruggeri, MD, Paul Schimmel, PhD

Blood (2016) 128 (22): 1476.

https://doi.org/10.1182/blood.V128.22.1476.1476

Published: 2016

Journal Articles

Toll like Receptor 2/6 but Not 1/2 Signaling Promotes Leukemogenesis in a Mouse Model of Myelodysplastic Syndrome

Sima T Bhatt, MD, Darlene Monlish, PhD, Eric J. Duncavage, MD, John Luke Keller, Bilski Rachel, BS, Tanja Le, Matthew J. Walter, MD, Laura G. Schuettpelz, MD PhD

Blood (2016) 128 (22): 1970.

https://doi.org/10.1182/blood.V128.22.1970.1970

Published: 2016

Journal Articles

Longitudinal Assessment of CLL Patients Under Ibrutinib Treatment Reveals Maintained Capacity to Respond to Microenvironmental Stimuli through the Toll-like Receptors

Maria Gounari, PhD, Stavroula Ntoufa, PhD, Konstantia Kotta, PhD, Maria Giovanna Vilia, Athanasia Nenou, Marina Gerousi, Lydia Scarfò, MD, Aliki Xochelli, MD PhD, Eleonora Fonte, PhD, Marta Coscia, MD PhD, Alessandra Tedeschi, Niki Stavroyianni, MD, Marta Muzio, PhD, Kostas Stamatopoulos, MD PhD, Paolo Ghia

Blood (2016) 128 (22): 2025.

https://doi.org/10.1182/blood.V128.22.2025.2025

Published: 2016

NARROW

Non-Canonical MYD88/TIRAP-Dependent Anti-Inflammatory Function of Pro-Coagulant Factor VIII

Utility of FDG-PET/CT in Lymphoblastic Lymphoma

Polymorphisms in Inflammatory Genes Modulate the Occurrence of Clinical Complications in Patients with Sickle Cell Disease

A Polymorphism in Toll-like Receptor 2 Gene Is Associated with Occurrence of Bacterial Infections in Sickle Cell Disease Patients

A Clinical Study of Tomaralimab (OPN-305), a Toll-like Receptor 2 (TLR-2) Antibody, in Heavily Pre-Treated Transfusion Dependent Patients with Lower Risk Myelodysplastic Syndromes (MDS) That Have Received and Failed on Prior Hypomethylating Agent (HMA) Therapy

Inhibition of High Mobility Group Box-1 (HMGB1) Eradicates Human Myelodysplastic Syndrome

Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS

Acquired Somatic Mutations in T Cells in Patients with Aplastic Anemia and Hypoplastic Myelodysplastic Syndromes

Elucidation of Autoinflammatory Mechanism in Pigt-PNH

Stromal-Cells Downregulate MiR-23a-5p Levels in Myeloid Leukemic Cells to Activate Protective-Autophagy Against Chemotherapeutic Agents

Innate Immune Activation Via TLR9 May Enhance Antibody Formation Against Factors VIII and IX in Protein and Gene Therapy

Identification of Somatic Mutations in Expanded T Cell Clones of Patients with Chronic Graft-Versus-Host Disease (GVHD)

Loss of Toll-like Receptor 2 Results in Accelerated Leukemogenesis in the NUP98-HOXD13 Mouse Model of MDS

Ruxolitinib Inhibits Toll-like Receptor or GM-CSF, but Not TREM-1 Mediated Neutrophil Activation

Toll-like Receptor 2 Costimulation Potentiates the Antitumor Efficacy of CAR T Cells

Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2

Toll-Like Receptors: Mechanism and Relation to Human Populations

Extracellular Tyrosyl-tRNA Synthetase Is a Potent Stimulator of Thrombocytopoiesis

Toll like Receptor 2/6 but Not 1/2 Signaling Promotes Leukemogenesis in a Mouse Model of Myelodysplastic Syndrome

Longitudinal Assessment of CLL Patients Under Ibrutinib Treatment Reveals Maintained Capacity to Respond to Microenvironmental Stimuli through the Toll-like Receptors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only